Central nervous system and cardiovascular toxicity are well-known side effe
cts of bupivacaine. We report a case of bupivacaine-induced myocardial depr
ession and cardiogenic pulmonary edema. A previously healthy woman develope
d soon after bupivacaine epidural injection of 5 mL 0.5% (25 mg) cardiogeni
c shock complicated with pulmonary edema. There were pronounced rales on au
scultation with a butterfly sign on chest radiograph. A cardiac ultrasound
showed reduced myocardial contractility, diffuse hypokinesia, left ventricu
lar ejection fraction (LVEF) 25%, mitral and pulmonary insufficiency. Right
heart catheterization showed increased pulmonary artery wedge pressure (34
mm Hg) and a pulmonary artery pressure of 48 over 33 mm Hg. These findings
suggest myocardial depression owing to bupivacaine sodium channel blocking
of myocardial nerve and tissue and subsequent reduction of myocardial cont
ractility. The patient completely recovered with normalization of clinical,
roentenographic, ultrasound, and hemodynamic findings and discharged 10 da
ys later in good condition.